Inspira Technologies OXY B.H.N. Ltd. announced a strategic shift to expedite the commercialization of its FDA-cleared INSPIRA ART100 system, while still developing its product portfolio. The ART100 ...
Implementation of "Treat All," which removed CD4-based clinical staging criteria for antiretroviral therapy (ART) initiation, did not accelerate ART coverage gains or AIDS mortality reductions among ...
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Incredibuild, the world leader in build acceleration, today announced the launch of a first-of-its-kind platform, purpose-built for the era of AI-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results